Litigation Details for In Re Glumetza Antitrust Litigation (N.D. Cal. 2019)
✉ Email this page to a colleague
In Re Glumetza Antitrust Litigation (N.D. Cal. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-09-18 |
| Court | District Court, N.D. California | Date Terminated | 2022-12-07 |
| Cause | 15:1 Antitrust Litigation | Assigned To | William Haskell Alsup |
| Jury Demand | Both | Referred To | Robert M. Illman |
| Patents | 6,340,475; 6,488,962; 6,635,280; 6,723,340; 7,780,987; 8,323,692 | ||
| Link to Docket | External link to docket | ||
Details for In Re Glumetza Antitrust Litigation (N.D. Cal. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-09-18 | 1 | Complaint | 6,340,475 (‘475 patent) 9/16/2016 20 6,635,280 (‘280 patent) …Book patent (the ‘692 patent), as well as two non-Orange Book listed patents 20 (the ‘667 patent and…listed patent(s) and/or the patent is 2 invalid and unenforceable. Simply by listing the patents in the…and U.S. Patent No. 8,329,215 (“the ‘215 patent”)). 21 191. The ‘215 patent, like the ‘667…plaintiffs in the 8 patent lawsuit, Assertio/Santarus, to the defendant in the patent lawsuit, Lupin. Lupin | External link to document |
| 2020-03-05 | 188 | Order on Motion to Dismiss | four relevant patents: U.S. Patent Nos. 21 6,340,475; 6,635,280; 6,488,962… 16 for the patent barrier remains. New brand-drug applicants must list the patents (if any) covering…brand drug, that the relevant patents have expired, or that such patents are invalid or will not be …infringe the patents 4 because it designed around the patents using a… the patent suit, Lupin would stop challenging the 18 patent, and | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
